Agios Pharma (AGIO) PT Raised to $86 at Needham & Company; 'Continued Execution'

February 14, 2018 12:48 PM

Needham & Company raised its price target on Agios Pharma (NASDAQ: AGIO) to $86.00 (from $72.00) while maintaining a Buy ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found